These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33516374)

  • 41. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-β
    Negahdary M; Heli H
    Mikrochim Acta; 2019 Nov; 186(12):766. PubMed ID: 31713687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition.
    Meier SR; Syvänen S; Hultqvist G; Fang XT; Roshanbin S; Lannfelt L; Neumann U; Sehlin D
    J Nucl Med; 2018 Dec; 59(12):1885-1891. PubMed ID: 29853653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging and spatial distribution of beta-amyloid peptide and metal ions in Alzheimer's plaques by laser ablation-inductively coupled plasma-mass spectrometry.
    Hutchinson RW; Cox AG; McLeod CW; Marshall PS; Harper A; Dawson EL; Howlett DR
    Anal Biochem; 2005 Nov; 346(2):225-33. PubMed ID: 16214103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abeta(1-40) peptide radiopharmaceuticals for brain amyloid imaging: (111)In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections.
    Kurihara A; Pardridge WM
    Bioconjug Chem; 2000; 11(3):380-6. PubMed ID: 10821654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrasmall
    Cai J; Yi P; Miao Y; Liu J; Hu Y; Liu Q; Feng Y; Chen H; Li L
    ACS Appl Mater Interfaces; 2020 Jun; 12(24):26812-26821. PubMed ID: 32427456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging gold nanoparticles in mouse liver by laser ablation inductively coupled plasma mass spectrometry.
    Li Q; Wang Z; Mo J; Zhang G; Chen Y; Huang C
    Sci Rep; 2017 Jun; 7(1):2965. PubMed ID: 28592817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry.
    Ikegawa M; Nirasawa T; Kakuda N; Miyasaka T; Kuzuhara Y; Murayama S; Ihara Y
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30907869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aptamer conjugated polydopamine-coated gold nanoparticles as a dual-action nanoplatform targeting β-amyloid peptide for Alzheimer's disease therapy.
    Qin J; Guan Y; Li Z; Guo X; Zhang M; Wang D; Tang J
    J Mater Chem B; 2022 Oct; 10(41):8525-8534. PubMed ID: 36222089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.
    Shi J; Perry G; Berridge MS; Aliev G; Siedlak SL; Smith MA; LaManna JC; Friedland RP
    J Nucl Med; 2002 Aug; 43(8):1044-51. PubMed ID: 12163630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative Characterization of Gold Nanoparticles by Coupling Thin Layer Chromatography with Laser Ablation Inductively Coupled Plasma Mass Spectrometry.
    Yan N; Zhu Z; Jin L; Guo W; Gan Y; Hu S
    Anal Chem; 2015 Jun; 87(12):6079-87. PubMed ID: 26005902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
    Thal DR; Ronisz A; Tousseyn T; Rijal Upadhaya A; Balakrishnan K; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Otto M; Beach TG; Lilja J; Heurling K; Chakrabarty A; Ismail A; Buckley C; Smith APL; Kumar S; Farrar G; Walter J
    Acta Neuropathol Commun; 2019 Nov; 7(1):178. PubMed ID: 31727169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bifunctional Fluorescent/Raman Nanoprobe for the Early Detection of Amyloid.
    Xia Y; Padmanabhan P; Sarangapani S; Gulyás B; Vadakke Matham M
    Sci Rep; 2019 Jun; 9(1):8497. PubMed ID: 31186449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B
    Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Porphyrinic Metal-Organic Framework PCN-224 Nanoparticles for Near-Infrared-Induced Attenuation of Aggregation and Neurotoxicity of Alzheimer's Amyloid-β Peptide.
    Wang J; Fan Y; Tan Y; Zhao X; Zhang Y; Cheng C; Yang M
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36615-36621. PubMed ID: 30338980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.